ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review

ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review

Qinchuan Yu,&ast; Zhiqiang Zhao,&ast; He Wang, Lieyang Wang Department of Hematology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, People’s Republic of Chin...

Full description

Bibliographic Details
Main Authors:	Yu Q, Zhao Z, Wang H, Wang L
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-10-01
Series:	OncoTargets and Therapy
Subjects:	cll alcl richter’s syndrome ig rearrangement
Online Access:	https://www.dovepress.com/alk-positive-anaplastic-large-cell-lymphoma-in-a-patient-with-chronic--peer-reviewed-fulltext-article-OTT

Similar Items

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
by: Tadeusz Robak, et al.
Published: (2022-11-01)

An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive
by: Suzanne D. Turner
Published: (2017-10-01)

Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma—Experience from an Indian Center
by: Muthiah Vaikundaraja Indhuja, et al.

Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
by: Yuan Wang, et al.
Published: (2022-02-01)

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation
by: Valentín Ortiz-Maldonado, et al.
Published: (2022-01-01)

Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell Lymphoma
by: Giulia Arosio, et al.
Published: (2021-09-01)

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma
by: Vijay Kumar Singh, et al.
Published: (2019-09-01)

Alectinib, an anaplastic lymphoma kinase (ALK) inhibitor, as a bridge to allogeneic stem cell transplantation in a patient with ALK‐positive anaplastic large‐cell lymphoma refractory to chemotherapy and brentuximab vedotin
by: Ritsuko Nakai, et al.
Published: (2019-12-01)

Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma
by: Camille Daugrois, et al.
Published: (2021-11-01)

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
by: Serena Stadler, et al.
Published: (2018-04-01)

Cardiac anaplastic large cell lymphoma in an 8-year old boy
by: Melchior Lauten, et al.
Published: (2014-01-01)

U-RT1 – A new model for Richter transformation
by: Teresa Schmid, et al.
Published: (2021-01-01)

BRG1 and NPM-ALK Are Co-Regulated in Anaplastic Large-Cell Lymphoma; BRG1 Is a Potential Therapeutic Target in ALCL
by: Gavin D. Garland, et al.
Published: (2021-12-01)

Uncommon spinal involvement of ALK-positive anaplastic large cell lymphoma: A pediatric case report and literature review
by: Mohammed Al amine El farissi, et al.
Published: (2024-01-01)

Chronic Lymphocytic Leukemia Progression Diagnosis with Intrinsic Cellular Patterns via Unsupervised Clustering
by: Pingjun Chen, et al.
Published: (2022-05-01)

From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)
by: Michael T. Werner, et al.
Published: (2017-10-01)

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome
by: Benjamin M. Heyman, et al.
Published: (2022-12-01)

Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy
by: Takashi Onaka, et al.
Published: (2018-05-01)

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BI-ALCL)
by: R. Sabetta, et al.
Published: (2020-03-01)

B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
by: Zhenguo Zi, et al.
Published: (2020-12-01)

Biology and Treatment of Richter Transformation
by: Adalgisa Condoluci, et al.
Published: (2022-03-01)

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse
by: Christopher N. Nguyen, BA, et al.
Published: (2021-11-01)

ALK signaling and target therapy in anaplastic large cell lymphoma
by: Fabrizio eTabbo, et al.
Published: (2012-05-01)

Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment
by: Xin-Rui Zhang, et al.
Published: (2022-03-01)

Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis
by: Guillermo Ramos-Gallardo, et al.
Published: (2017-01-01)

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
by: Ivonne A. Montes-Mojarro, et al.
Published: (2018-04-01)

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation
by: Kazunori Kawasoe, et al.
Published: (2023-10-01)

Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent
by: Chuquan Shang, et al.
Published: (2021-01-01)

Updates in pathobiological aspects of anaplastic large cell lymphoma
by: Rui Wu, et al.
Published: (2023-09-01)

Extreme Hypoglycaemia in Anaplastic Large Cell Lymphoma
by: Lidor Akavia, et al.
Published: (2017-03-01)

Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
by: Christine Damm-Welk, et al.
Published: (2022-03-01)

Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers?
by: Federica Lovisa, et al.
Published: (2021-02-01)

Atypical Chronic Lymphocytic Leukemia—The Current Status
by: Tadeusz Robak, et al.
Published: (2023-09-01)

The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
by: Schieber M, et al.
Published: (2019-03-01)

Anaplastic large cell lymphoma of breast masquerading suppurative mastitis on cytology
by: Sailuja Maharjan, et al.
Published: (2022-08-01)

Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
by: Smeeta Gejendra, et al.
Published: (2015-11-01)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
by: Tamar Tadmor, et al.
Published: (2021-10-01)

Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma
by: Hyokyung Yoo, et al.
Published: (2022-03-01)

Breast Reconstruction after Breast Implant-Associated Anaplastic Large Cell Lymphoma Treatment: A Case Report and Literature Review
by: Won-Seob Lee, et al.
Published: (2023-02-01)

Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
by: Yichen Wang, et al.
Published: (2022-01-01)